ASUR

Asure is a cloud HCM/payroll SaaS with the economics of a decent software business trapped inside an ugly GAAP income statement. Gross margin is a SaaS-grade 79.7% ($94.9M gross profit, +15.5%), the client base is broad and sticky (100,000+ clients per the 10-K, ~35% direct and the rest through Reseller Partners), and — most importantly — operating cash flow is genuinely positive and surging to $22.2M (+136.7%) against tiny $787K capex. On a $232M market cap that is roughly a 9-10% cash yield, and the headline net loss is heavily a function of $26.4M of D&A (largely non-cash amortization of acquired intangibles) rather than cash burn. At P/S 2.0 for an 80%-gross-margin recurring-revenue model, the stock is not expensively priced, which is what keeps this off the sell/avoid list.

The problem is quality and direction. Net income has been negative every year except FY2021 and is steadily widening: -$14.5M, -$9.21M, -$11.8M, -$13.1M. Operating margin is still -7.1%, ROE -6.6%, and the accumulated deficit sits at -$320M. The balance sheet just took on real leverage — long-term debt exploded from ~$5.7M to $63.3M (+1008.5%) against only $25.2M of cash, pushing liabilities/equity to 1.69x. Meanwhile R&D was cut 28.3% to just $5.6M even as management leans on 'RPA, AI, and development partnerships' as its competitive differentiation in the MD&A; funding differentiation by shrinking R&D is a tension the filing doesn't resolve. Share count also crept up 5.2%, diluting holders.